Journal article · 2024

Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells

Yang Liu, Rui Niu, Xiaodong Zhang, Bin Zhang, Xiaokai Chen, Jingjing Guo, Shuyan Song, Yinghui Wang, Hongjie Zhang, Yanli Zhao

ACS Nano, 18(19), 12386–12400 · Published 3 May 2024 · DOI 10.1021/acsnano.4c01518

View at the publisherCite this paper

In brief

“Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells” is a 2024 journal article by Yang Liu and 9 co-authors, published in ACS Nano. OpenAlex counts 64 citations as of 19 November 2026, which puts it in the top 2% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
64
Most cited in
2026 (29)
Field-weighted impact
5.81
References
52
Authors
10

Abstract

Current cancer vaccines face challenges due to an immunosuppressive tumor microenvironment and their limited ability to produce an effective immune response. To address the above limitations, we develop a 3-(2-spiroadamantyl)-4-methoxy-4-(3-phosphoryloxy)-phenyl-1,2-dioxetane (alkaline phosphatase substrate) and XMD8-92 (extracellular signal-regulated kinase 5 inhibitor)-codelivered copper-tetrahydroxybenzoquinone (Cu-THBQ/AX) nanosized metal–organic framework to in situ-generate therapeutic vaccination. Once inside the early endosome… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, Y., Niu, R., Zhang, X., Zhang, B., Chen, X., Guo, J., Song, S., Wang, Y., Zhang, H., & Zhao, Y. (2024). Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells. ACS Nano, 18(19), 12386–12400. https://doi.org/10.1021/acsnano.4c01518

MLA 9

Liu, Yang, et al. “Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells.” ACS Nano, vol. 18, no. 19, 2024, pp. 12386–12400. https://doi.org/10.1021/acsnano.4c01518.

Chicago

Liu, Yang, Rui Niu, Xiaodong Zhang, Bin Zhang, Xiaokai Chen, Jingjing Guo, Shuyan Song, Yinghui Wang, Hongjie Zhang, and Yanli Zhao. 2024. “Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells.” ACS Nano 18 (19): 12386–12400. https://doi.org/10.1021/acsnano.4c01518.

Harvard

Liu, Y. et al. (2024) ‘Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells’, ACS Nano, 18(19), pp. 12386–12400. doi:10.1021/acsnano.4c01518.

IEEE

Y. Liu et al., “Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells,” ACS Nano, vol. 18, no. 19, pp. 12386–12400, 2024, doi: 10.1021/acsnano.4c01518.

BibTeX

@article{liu2024metal,
  title     = {{Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells}},
  author    = {Liu, Yang and Niu, Rui and Zhang, Xiaodong and Zhang, Bin and Chen, Xiaokai and Guo, Jingjing and Song, Shuyan and Wang, Yinghui and Zhang, Hongjie and Zhao, Yanli},
  journal   = {ACS Nano},
  year      = {2024},
  volume    = {18},
  number    = {19},
  pages     = {12386--12400},
  doi       = {10.1021/acsnano.4c01518},
  url       = {https://doi.org/10.1021/acsnano.4c01518}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202488
20252727
20262929

Its field-weighted citation impact is 5.81: it has been cited 5.81 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • XMD8-92
  • efferocytosis
  • macrophages
  • pyroptosis
  • cuproptosis
  • secondary necrosis
  • reactive oxygen species
  • Fenton-like reaction

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Liu, Y., Niu, R., Zhang, X., Zhang, B., Chen, X., Guo, J., Song, S., Wang, Y., Zhang, H., & Zhao, Y. (2024). Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells. ACS Nano, 18(19), 12386–12400. https://doi.org/10.1021/acsnano.4c01518

How many times has this paper been cited?

64 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yang Liu, Rui Niu, Xiaodong Zhang, Bin Zhang, Xiaokai Chen, Jingjing Guo, Shuyan Song, Yinghui Wang, Hongjie Zhang, Yanli Zhao.

What is the DOI of this paper?

10.1021/acsnano.4c01518, permanently at https://doi.org/10.1021/acsnano.4c01518. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.